168 related articles for article (PubMed ID: 18355839)
1. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.
Routh JC; Ashley RA; Sebo TJ; Lohse CM; Husmann DA; Kramer SA; Kwon ED
J Urol; 2008 May; 179(5):1954-9; discussion 1959-60. PubMed ID: 18355839
[TBL] [Abstract][Full Text] [Related]
2. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.
Routh JC; Grundy PE; Anderson JR; Retik AB; Kurek KC
J Urol; 2013 Apr; 189(4):1487-92. PubMed ID: 23154206
[TBL] [Abstract][Full Text] [Related]
3. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
[TBL] [Abstract][Full Text] [Related]
4. HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor.
Ragab SM; Samaka RM; Shams TM
Pathol Oncol Res; 2010 Mar; 16(1):61-7. PubMed ID: 19609744
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biologic significance of nuclear unrest in Wilms tumor.
Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
[TBL] [Abstract][Full Text] [Related]
6. Management of bilateral Wilms tumor over three decades: The perspective of a single center.
User IR; Ekinci S; Kale G; Akyüz C; Büyükpamukçu M; Karnak I; Çiftçi AÖ; Tanyel FC; Şenocak ME
J Pediatr Urol; 2015 Jun; 11(3):118.e1-6. PubMed ID: 25842994
[TBL] [Abstract][Full Text] [Related]
7. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
8. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.
Dome JS; Liu T; Krasin M; Lott L; Shearer P; Daw NC; Billups CA; Wilimas JA
J Pediatr Hematol Oncol; 2002; 24(3):192-8. PubMed ID: 11990305
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
Salama A; Kamel A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
[TBL] [Abstract][Full Text] [Related]
10. Significance of B7-H1 overexpression in kidney cancer.
Thompson RH; Kwon ED
Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.
Crispen PL; Sheinin Y; Roth TJ; Lohse CM; Kuntz SM; Frigola X; Thompson RH; Boorjian SA; Dong H; Leibovich BC; Blute ML; Kwon ED
Clin Cancer Res; 2008 Aug; 14(16):5150-7. PubMed ID: 18694993
[TBL] [Abstract][Full Text] [Related]
12. Autophagy related markers (Beclin-1 and ATG4B) are strongly expressed in Wilms' tumor and correlate with favorable histology.
Guimei M; Eladl MA; Ranade AV; Manzoor S
Histol Histopathol; 2019 Jan; 34(1):47-56. PubMed ID: 29989143
[TBL] [Abstract][Full Text] [Related]
13. Increased tissue factor expression and poor nephroblastoma prognosis.
Maciel EO; Carvalhal GF; da Silva VD; Batista EL; Garicochea B
J Urol; 2009 Oct; 182(4):1594-9. PubMed ID: 19683742
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte elevated gene-1 overexpression in histologically favorable Wilms tumor is related to poor prognosis.
Guo F; Zhang LJ; Liu W; Wang G; Liu HY; Wang YL; Ma R; Wu RD
J Pediatr Urol; 2014 Apr; 10(2):317-23. PubMed ID: 24119914
[TBL] [Abstract][Full Text] [Related]
15. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
16. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
[TBL] [Abstract][Full Text] [Related]
17. Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray.
Mehrazma M; Madjd Z; Kalantari E; Panahi M; Hendi A; Shariftabrizi A
Fetal Pediatr Pathol; 2013 Jun; 32(3):192-204. PubMed ID: 22830353
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
[TBL] [Abstract][Full Text] [Related]
19. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
20. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
Thompson RH; Dong H; Kwon ED
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
